Sudarshan Pharma announces acquisition of stake in this healthcare company - Details

Specialty Chemicals company Sudarshan Pharma Industries Ltd has informed exchanges that its board has approved the acquisition of Ishwari Healthcare Private Limited, engaged in the business of medical and surgical instruments.

The company said that the board has approved the acquisition of 2,09,200 equity shares of Rs 10 each.

"...approved to acquire 2,09,100 equity shares of Rs10 each of Ishwari Healthcare Private Limited equivalent to 51 per cent of the paid up equity share capital of the company and enter into Share Purchase Agreement. Upon completion of the acquisition, Ishwari Healthcare would become a subsidiary of the company," the filing read.

Meanwhile, the company recently announced the split of equity shares.

According to an exchange filing, the company's board met recently to consider a proposal for the proposal for sub-division / split of equity shares, presently having a face value of Rs 10 each. The split will take effect in the ratio of 10:1. It means that each stock of Rs 10 face value will split into 10 shares of Re 1 each.

Meanwhile, equity benchmark indices rallied in early trade on Tuesday amid buying in IT and bank stocks along with a sharp cut in Brent crude oil prices.

The BSE Sensex climbed 327.39 points to 82,300.44 in early trade. The NSE Nifty went up by 84.1 points to 25,212.05.
From the 30 Sensex firms, Asian Paints, Bharti Airtel, Infosys, Mahindra & Mahindra, Titan, Bajaj Finance, HCL Technologies and ICICI Bank were among the major gainers.

IT services major HCL Technologies (HCLTech) on Monday reported a 10.51 per cent increase in consolidated net profit to Rs 4,235 crore in the July-September quarter of FY25, as the company raised the lower band of its growth guidance on the back of better-than-expected performance.